Quartuccio L, Sonaglia A, Pecori D, Peghin M, et al. Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6. J Med Virol 2020 Jun 9. doi: 10.1002/jmv.26149.
PMID: 32515499